I write to you to share my deep concerns. As a public health professional, a psychologist and an educator, it is clear to me that children and young people, although practically unaffected by the virus, have been the biggest victims of the response.
ARTICLESVoices | Voices // Government Responsibility
In response to plans to roll out the COVID-19 vaccination program to children and young people, PANDA sent this letter to all Members of European Parliament.
A professor of Computer Science and Technology sent a well referenced letter to authorities in India, as most schools remain closed.
The UK Medical Freedom Alliance (UKMFA), an alliance of medical professionals, scientists and lawyers, wrote an open letter to inform schools heads on the impacts of a proposed COVID-19 vaccine rollout to schoolchildren.
The Public Emergency Council is a spontaneous initiative of doctors and researchers who felt that it was no longer possible to remain silent in the face of the outgoing government’s steps to contain the COVID- 19 pandemic.
This legal letter from Lexcel (UK) to Sir Simon Stevens (CEO, NHS) is an excellent summary of all that is wrong with the NHS response to COVID-19.
About 4 weeks ago, it started getting bad again. Almost like before Christmas, which was like a war zone, I won’t lie. And when your face is pressed up against that suffering and death, it is hard not to think the worst and get pulled into the abyss.
The UK has a pandemic plan. It reflects the democratic traditions of the nation, recognising that an informed and empowered public will voluntarily take action to protect themselves, their families and communities during a pandemic. Faced with SARS-CoV-2, the UK, along with most other countries and the World Health Organisation, discarded years of pandemic planning.
You don’t have to be spiritual to understand unity consciousness—you are conscious of your human unity whenever you talk to a friend, look at a new-born baby, cry at a movie, hug a loved one or make love.
A drug safety physician’s alert to Dr. Peter Marks (U.S. Food and Drug Administration) regarding the need for clear guidance or regulation concerning COVID-19 vaccines as default investigational products in non-vaccine clinical trials.